COGT earnings date and last-quarter result: last quarter miss, P/E -12.84. Updated 2026-07-23.
Cogent Biosciences (COGT) Research Hub
Cogent Biosciences (COGT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 30.91 USD (-0.96%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -12.84, market cap 6.63B. This hub links to the full technical, earnings and options research available for COGT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 30.91 USD (-0.96%) |
| 52-week range | 27.735 USD – 43.39 USD |
| Trend regime | Range |
| 14-day RSI | 53.3 (Neutral) |
| Trailing P/E | -12.84 |
| Market cap | 6.63B |
| Dividend yield | 0.00% |
Available research for COGT
Covered Call on COGT: how it works, illustrative setup around the real 30.91 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on COGT: how it works, illustrative setup around the real 30.91 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on COGT: how it works, illustrative setup around the real 30.91 USD price, max profit/loss, breakeven and when to use it. Educational.
COGT technical analysis: range, last 30.91 USD, RSI 53.3, 52w range 27.735 USD–43.39 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is COGT in?
Cogent Biosciences (COGT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is COGT in an uptrend or downtrend?
As of 2026-10-26, COGT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is COGT's trailing P/E ratio?
COGT's trailing P/E is -12.84, with a market cap of 6.63B. See the earnings research page for full valuation detail.